| Abstrakt: |
Genprex, Inc. filed a Form 10-Q with the U.S. Securities and Exchange Commission on November 13, 2024. This filing provides unaudited financial statements and offers insight into the company's financial status throughout the year. The Form 10-Q is a quarterly report that must be submitted by most reporting companies within 45 days of the close of each fiscal quarter. Genprex, Inc. is a biopharmaceutical company located in Austin, Texas, focusing on healthcare biotechnology. [Extracted from the article] |
